Primer

Piotech Primer

Piotech Inc. (拓荆科技, SHSE: 688072) is a Chinese semiconductor capital-equipment maker that designs, builds, and services thin-film deposition tools — primarily PECVD, ALD, SACVD, and HDPECVD systems — used by domestic foundries and memory makers to fabricate logic chips, memory, and advanced packaging. The company earns revenue from selling these systems and from related installation, spares, and process-support services, so its top line tracks Chinese fab capital spending rather than end-consumer demand. Listed on Shanghai's STAR Market in April 2022 and backed by China's National Integrated Circuit Industry Investment Fund, Piotech is positioned as one of the country's leading domestic alternatives to Applied Materials, Lam Research, and ASM International in deposition.

Share Price — 5-Year View

Piotech's price rose from roughly CN¥40 (5-year low) in 2021 to CN¥529.94 on May 15, 2026 — a 5-year cumulative gain near 725%. The journey was not smooth: shares were nearly flat year-on-year through mid-2025, then rallied more than threefold in the six months to mid-May 2026 as 2025 results and Q1 2026 earnings confirmed a sharp profit recovery. Intraday and daily prices in early May 2026 traded as wide as CN¥468.86 to CN¥565.00.

Revenue Growth And Net Margin

Revenue compounded at roughly 43% per year over five years to FY2025, but margins have moved in the opposite direction in 2024–2025 — FY2025 net margin slipped to 14.2% from 16.7% in FY2024 and a peak above 21% in FY2022, as operating expenses scaled faster than receipts. Consensus revenue for FY2026 sits near CN¥8.4B, with analysts modeling a margin rebound toward 24% as Q1 2026 already returned to profit (CN¥570.6M net income on CN¥1,112M sales) after a Q1 2025 loss. FY2023 figures are not in the public summaries we could verify, so that year is omitted from the chart.

Business In One Page

Piotech is a process-equipment specialist focused on thin-film deposition — the precision layering of dielectric and barrier films that enables modern logic, memory, and 3D packaging. Its product portfolio breaks roughly into three families. PECVD (plasma-enhanced chemical vapor deposition) systems are the largest line and the historical foothold, used heavily in memory chip manufacturing for dielectric films; the company's PF-300T was its first mass-production multi-chamber system. ALD (atomic layer deposition) tools, including 12-inch systems certified for production in 2018, support conformal films in high-aspect-ratio structures critical to advanced logic. SACVD (sub-atmospheric chemical vapor deposition) addresses gap-fill in wafer manufacturing. Newer adjacencies include high-density plasma PECVD and hybrid bonding equipment for wafer-level 3D integration.

Customers are domestic Chinese foundries, memory makers, and packaging houses; tools are reportedly installed on roughly 60 production lines across 20-plus regions including mainland China and Taiwan. The Company indicates it mainly sells within the domestic market, which means its growth is driven by Chinese fab capex cycles and the national push for semiconductor self-sufficiency. Headquarters and manufacturing sit in Shenyang (Liaoning Province), with subsidiaries in Beijing, Shanghai, Haining, and the United States supporting sales and service. The company employs about 1,695 people. Strategic equity holders include AMEC Semiconductor Equipment (~7.3%) and China Asset Management (~4.3%), with the National IC Industry Investment Fund a notable backer historically. Ms. Jing Liu has served as CEO since January 2023; Mr. Guang Quan Lü chairs the board.

What Changed Recently

• Q1 2026 inflection (Apr 27, 2026): Revenue surged 56.97% year-over-year to CN¥1,112.43M and net income reached CN¥570.6M, reversing a CN¥146.95M net loss in Q1 2025. Management attributed the swing to advanced equipment sales and a lower expense ratio, though operating cash flow turned negative on heavier procurement and payroll (TradingView/Quartr, MarketScreener).
• FY2025 results (Feb 27 preliminary, Apr 27 final): Revenue grew 59% to CN¥6.52B and net income rose 35% to CN¥926.7M, with EPS of CN¥3.32 (vs. CN¥2.48 in FY2024); profit margin compressed to 14% from 17% on expense growth (Simply Wall St, MarketScreener).
• Daiwa upgrade (Apr 29, 2026): Daiwa Securities lifted its rating on Piotech to Buy from Hold with a 565-yuan price target — set near the multi-week intraday high (MarketScreener).
• Capital raise and shareholder moves (Sep 2025–Jan 2026): Piotech announced plans to raise approximately CN¥4.6B through a private placement (Sep 11, 2025). Around the same window, the National IC Industry Investment Fund signaled plans to cut its stake (Nov 20, 2025) and another shareholder said it would unload up to 1.3% of the company (Jan 7, 2026) (MarketScreener).
• Sanctions backdrop: Late-2024 U.S. export-control actions targeting Chinese semiconductor toolmakers continue to shape the investment narrative, framed by some outlets as accelerating share gains for domestic equipment suppliers ("China's Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions," Yahoo Finance / 24/7 Wall St., May 2026).

Valuation Snapshot

At CN¥529.94, Piotech's market cap is roughly CN¥149B (about US$21.9B) on a free-float of about 72%. Sell-side consensus implies CN¥8.38B in FY2026 revenue and CN¥2.04B in net income, scaling to CN¥11.42B and CN¥2.75B in FY2027. On those numbers, the stock trades at roughly 75.7x FY2026E earnings (54x FY2027E) and 17.2x FY2026E sales (12.5x FY2027E) — premium multiples that price the company as a domestic-China share-gain story in deposition equipment, sitting in the same conversation as A-share peers like NAURA Technology and Advanced Micro-Fabrication (AMEC) rather than a mature-market comparable like Applied Materials. The market is essentially capitalizing several years of 25-30% revenue growth and a margin recovery already evident in Q1 2026; trailing valuation looks expensive (P/E on FY2025 EPS of CN¥3.32 is roughly 160x), so the bull case depends on the forward growth holding (Yahoo Finance, MarketScreener, Simply Wall St).

Risks And Watchpoints

• U.S. export controls and sanctions on Chinese chip toolmakers could affect access to inputs, software, and end-customer demand patterns; the policy backdrop has tightened repeatedly since late 2024.
• Margin trajectory: Net margin fell from 21% in FY2022 to 14% in FY2025 as expenses ran ahead of revenue. The implicit 24% FY2026 margin in consensus assumes a sharp inflection that has been validated in Q1 only.
• Operating cash flow turned negative in Q1 2026 despite reported profit, on higher procurement and payroll; sustained capex- and working-capital intensity could pressure the balance sheet even as earnings rise.
• Liquidity and dilution: Quick ratio sits around 0.72 (below 1), and the company announced a ~CN¥4.6B private placement in September 2025, which would expand share count.
• Shareholder overhangs: The National IC Industry Investment Fund and another holder signaled stake reductions in late 2025/early 2026; a lock-up affecting certain A-shares ended on April 20, 2026, potentially adding to float supply.
• Customer and geographic concentration: Sales are heavily domestic and tied to a relatively small group of Chinese foundries and memory makers, so order timing from any one customer or fab project can swing quarterly results.
• Valuation reset risk: At 75x forward earnings, missing the consensus growth path — for any reason, including a softer fab capex cycle — would be a meaningful derating catalyst.

Data Limitations

Standardized financial and pricing data could not be retrieved through our usual vendor (the ticker is listed on the Shanghai Stock Exchange's STAR Market as 688072, and the vendor returned no match). The latest annual report, results announcement, and investor presentation PDFs were also not located on the company's IR site at run time. As a result, the figures and charts above are sourced from public market-data aggregators and recent news summaries (see citations); the price chart in particular is reconstructed from cited return windows rather than daily ticks, and FY2023 annual revenue is not shown because it was not confirmed in the sources reviewed.